These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 27634895)

  • 41. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
    Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
    Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical value of plasma scaffold protein SEC16A in evaluating hepatitis B-related liver cirrhosis and hepatocellular carcinoma].
    Dong C; Chang CD; Zhao DD; Zhang XX; Guo PL; Dou Y; Zhao SX; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):621-626. PubMed ID: 37400387
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
    Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
    Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypermethylation of the N-Myc Downstream-Regulated Gene 2 Promoter in Peripheral Blood Mononuclear Cells is Associated with Liver Fibrosis in Chronic Hepatitis B.
    Liu XY; Fan YC; Gao S; Zhao J; Li F; Zhang J; Wang K
    Tohoku J Exp Med; 2017 Feb; 241(2):155-163. PubMed ID: 28202850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population.
    Liu Y; Liu Y; Huang X; Sui J; Mo C; Wang J; Peng Q; Deng Y; Huang L; Li S; Qin X
    Infect Genet Evol; 2014 Oct; 27():69-76. PubMed ID: 25014269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Influence of ESR2 Gene Polymorphisms on Susceptibility to Hepatitis B Virus-Related Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma.
    Jie Z; Hongkun J; Shi Y; Fengxun Y; Xin L; Yijun M; Yu L
    Biochem Genet; 2024 Oct; 62(5):3946-3960. PubMed ID: 38245888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-stimulated gene 15 in hepatitis B-related liver diseases.
    Hoan NX; Van Tong H; Giang DP; Toan NL; Meyer CG; Bock CT; Kremsner PG; Song LH; Velavan TP
    Oncotarget; 2016 Oct; 7(42):67777-67787. PubMed ID: 27626177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression.
    Yuan XD; Wang JW; Fang Y; Qian Y; Gao S; Fan YC; Wang K
    Pathol Res Pract; 2020 May; 216(5):152914. PubMed ID: 32147273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
    Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
    Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases.
    Miao X; Peng C; Yan F; Guo X; Xia L; Song Q; An X; Wu G
    J Infect Dev Ctries; 2024 Apr; 18(4):618-626. PubMed ID: 38728647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy.
    Wang Y; Xiang X; Chen L; Cao Z; Bao R; Zhou H; Tang W; Lu J; Lin L; Xie Q; Bao S; Wang H
    Oncotarget; 2016 Sep; 7(36):58553-58562. PubMed ID: 27329718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic diversity, viraemic and aminotransferases levels in chronic infected hepatitis B patients from Cameroon.
    Tufon KA; Meriki HD; Anong DN; Mbunkah HA; Nkuo-Akenji T
    BMC Res Notes; 2016 Feb; 9():117. PubMed ID: 26899506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.
    Sinn DH; Lee J; Goo J; Kim K; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
    Hepatology; 2015 Sep; 62(3):694-701. PubMed ID: 25963803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.
    Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K
    Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.
    Sghaier I; Zidi S; Mouelhi L; Dabbech R; Ghazouani E; Brochot E; Stayoussef M; Yacoubi-Loueslati B
    Gene; 2015 Sep; 568(2):140-5. PubMed ID: 25982858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative HBV DNA and AST are strong predictors for survival after HCC detection in chronic HBV patients.
    Witjes CD; IJzermans JN; van der Eijk AA; Hansen BE; Verhoef C; de Man RA
    Neth J Med; 2011; 69(11):508-13. PubMed ID: 22279629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
    Wang K; Fan X; Fan Y; Wang B; Han L; Hou Y
    J Viral Hepat; 2007 Apr; 14(4):276-82. PubMed ID: 17381720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.